Role for Histone Deacetylase 1 in Human Tumor Cell Proliferation

REFERENCES

• Ahringer, J. 2000. NuRD and SIN3 histone deacetylase complexes in development. Trends Genet. 16:351–356.
   PubMed Web of Science ®Google Scholar
• Alcalay, M., N. Meani, V. Gelmetti, A. Fantozzi, M. Fagioli, A. Orleth, D. Riganelli, C. Sebastiani, E. Cappelli, C. Casciari, M. T. Sciurpi, A. R. Mariano, S. P. Minardi, L. Luzi, H. Muller, P. P. Di Fiore, G. Frosina, and P. G. Pelicci. 2003. Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair. J. Clin. Investig. 112:1751–1761.
   PubMed Web of Science ®Google Scholar
• Bartl, S., J. Taplick, G. Lagger, H. Khier, K. Kuchler, and C. Seiser. 1997. Identification of mouse histone deacetylase 1 as a growth factor-inducible gene. Mol. Cell. Biol. 17:5033–5043.
   PubMed Web of Science ®Google Scholar
• Bolden, J. E., M. J. Peart, and R. W. Johnstone. 2006. Anticancer activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. 5:769–784.
   PubMed Web of Science ®Google Scholar
• Choi, J. H., H. J. Kwon, B. I. Yoon, J. H. Kim, S. U. Han, H. J. Joo, and D. Y. Kim. 2001. Expression profile of histone deacetylase 1 in gastric cancer tissues. Jpn. J. Cancer Res. 92:1300–1304.
   PubMedGoogle Scholar
• Cobb, J., M. Miyaike, A. Kikuchi, and M. A. Handel. 1999. Meiotic events at the centromeric heterochromatin: histone H3 phosphorylation, topoisomerase II alpha localization and chromosome condensation. Chromosoma 108:412–425.
   PubMed Web of Science ®Google Scholar
• Cress, W. D., and E. Seto. 2000. Histone deacetylases, transcriptional control, and cancer. J. Cell Physiol. 184:1–16.
   PubMed Web of Science ®Google Scholar
• David, G., G. M. Turner, Y. Yao, A. Protopopov, and R. A. DePinho. 2003. mSin3-associated protein, mSds3, is essential for pericentric heterochromatin formation and chromosome segregation in mammalian cells. Genes Dev. 17:2396–2405.
   PubMedGoogle Scholar
• Ekwall, K., T. Olsson, B. M. Turner, G. Cranston, and R. C. Allshire. 1997. Transient inhibition of histone deacetylation alters the structural and functional imprint at fission yeast centromeres. Cell 91:1021–1032.
   PubMed Web of Science ®Google Scholar
• Finocchiaro, G., P. Parise, S. P. Minardi, M. Alcalay, and H. Muller. 2004. GenePicker: replicate analysis of Affymetrix gene expression microarrays. Bioinformatics 20:3670–3672.
   PubMedGoogle Scholar
• Fischle, W., F. Dequiedt, M. J. Hendzel, M. G. Guenther, M. A. Lazar, W. Voelter, and E. Verdin. 2002. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol. Cell 9:45–57.
   PubMed Web of Science ®Google Scholar
• Gao, L., M. A. Cueto, F. Asselbergs, and P. Atadja. 2002. Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J. Biol. Chem. 277:25748–25755.
   PubMed Web of Science ®Google Scholar
• Glaser, K. B., J. Li, M. J. Staver, R. Q. Wei, D. H. Albert, and S. K. Davidsen. 2003. Role of class I and class II histone deacetylases in carcinoma cells using siRNA. Biochem. Biophys. Res. Commun. 310:529–536.
   PubMed Web of Science ®Google Scholar
• Glaser, K. B., M. J. Staver, J. F. Waring, J. Stender, R. G. Ulrich, and S. K. Davidsen. 2003. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Mol. Cancer Ther. 2:151–163.
   PubMed Web of Science ®Google Scholar
• Gregoretti, I. V., Y. M. Lee, and H. V. Goodson. 2004. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J. Mol. Biol. 338:17–31.
   PubMed Web of Science ®Google Scholar
• Grozinger, C. M., and S. L. Schreiber. 2002. Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. Chem. Biol. 9:3–16.
   PubMed Web of Science ®Google Scholar
• Gurley, L. R., R. A. Walters, and R. A. Tobey. 1973. Histone phosphorylation in late interphase and mitosis. Biochem. Biophys. Res. Commun. 50:744–750.
   PubMed Web of Science ®Google Scholar
• Halkidou, K., L. Gaughan, S. Cook, H. Y. Leung, D. E. Neal, and C. N. Robson. 2004. Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. Prostate 59:177–189.
   PubMed Web of Science ®Google Scholar
• Hauser, C., B. Schuettengruber, S. Bartl, G. Lagger, and C. Seiser. 2002. Activation of the mouse histone deacetylase 1 gene by cooperative histone phosphorylation and acetylation. Mol. Cell. Biol. 22:7820–7830.
   PubMedGoogle Scholar
• Henderson, C., and C. Brancolini. 2003. Apoptotic pathways activated by histone deacetylase inhibitors: implications for the drug-resistant phenotype. Drug Resist. Updates 6:247–256.
   PubMed Web of Science ®Google Scholar
• Henderson, C., M. Mizzau, G. Paroni, R. Maestro, C. Schneider, and C. Brancolini. 2003. Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA). J. Biol. Chem. 278:12579–12589.
   PubMed Web of Science ®Google Scholar
• Hendzel, M. J., Y. Wei, M. A. Mancini, A. Van Hooser, T. Ranalli, B. R. Brinkley, D. P. Bazett-Jones, and C. D. Allis. 1997. Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106:348–360.
   PubMed Web of Science ®Google Scholar
• Hsu, J. Y., Z. W. Sun, X. Li, M. Reuben, K. Tatchell, D. K. Bishop, J. M. Grushcow, C. J. Brame, J. A. Caldwell, D. F. Hunt, R. Lin, M. M. Smith, and C. D. Allis. 2000. Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell 102:279–291.
   PubMed Web of Science ®Google Scholar
• Huang, B. H., M. Laban, C. H. Leung, L. Lee, C. K. Lee, M. Salto-Tellez, G. C. Raju, and S. C. Hooi. 2005. Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1. Cell Death Differ. 12:395–404.
   PubMed Web of Science ®Google Scholar
• Hubbert, C., A. Guardiola, R. Shao, Y. Kawaguchi, A. Ito, A. Nixon, M. Yoshida, X. F. Wang, and T. P. Yao. 2002. HDAC6 is a microtubule-associated deacetylase. Nature 417:455–458.
   PubMed Web of Science ®Google Scholar
• Humphrey, G. W., Y. Wang, V. R. Russanova, T. Hirai, J. Qin, Y. Nakatani, and B. H. Howard. 2001. Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1. J. Biol. Chem. 276:6817–6824.
   PubMed Web of Science ®Google Scholar
• Hutchins, J. R., and P. R. Clarke. 2004. Many fingers on the mitotic trigger: post-translational regulation of the Cdc25C phosphatase. Cell Cycle 3:41–45.
   PubMed Web of Science ®Google Scholar
• Ito, A., Y. Kawaguchi, C. H. Lai, J. J. Kovacs, Y. Higashimoto, E. Appella, and T. P. Yao. 2002. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J. 21:6236–6245.
   PubMed Web of Science ®Google Scholar
• Johnstone, R. W. 2002. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 1:287–299.
   PubMed Web of Science ®Google Scholar
• Johnstone, R. W., and J. D. Licht. 2003. Histone deacetylase inhibitors in cancer therapy: is transcription the primary target? Cancer Cell 4:13–18.
   PubMed Web of Science ®Google Scholar
• Kartmann, B., and D. Roth. 2001. Novel roles for mammalian septins: from vesicle trafficking to oncogenesis. J. Cell Sci. 114:839–844.
   PubMedGoogle Scholar
• Kawai, H., H. Li, S. Avraham, S. Jiang, and H. K. Avraham. 2003. Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha. Int. J. Cancer 107:353–358.
   PubMed Web of Science ®Google Scholar
• Khochbin, S., A. Verdel, C. Lemercier, and D. Seigneurin-Berny. 2001. Functional significance of histone deacetylase diversity. Curr. Opin. Genet. Dev. 11:162–166.
   PubMed Web of Science ®Google Scholar
• Kim, J. H., Y. K. Choi, H. J. Kwon, H. K. Yang, J. H. Choi, and D. Y. Kim. 2004. Downregulation of gelsolin and retinoic acid receptor beta expression in gastric cancer tissues through histone deacetylase 1. J. Gastroenterol. Hepatol. 19:218–224.
   PubMed Web of Science ®Google Scholar
• Kramer, O. H., P. Zhu, H. P. Ostendorff, M. Golebiewski, J. Tiefenbach, M. A. Peters, B. Brill, B. Groner, I. Bach, T. Heinzel, and M. Gottlicher. 2003. The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J. 22:3411–3420.
   PubMed Web of Science ®Google Scholar
• Lagger, G., A. Doetzlhofer, B. Schuettengruber, E. Haidweger, E. Simboeck, J. Tischler, S. Chiocca, G. Suske, H. Rotheneder, E. Wintersberger, and C. Seiser. 2003. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. Mol. Cell. Biol. 23:2669–2679.
   PubMed Web of Science ®Google Scholar
• Lagger, G., D. O'Carroll, M. Rembold, H. Khier, J. Tischler, G. Weitzer, B. Schuettengruber, C. Hauser, R. Brunmeir, T. Jenuwein, and C. Seiser. 2002. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 21:2672–2681.
   PubMed Web of Science ®Google Scholar
• Li, Y., G. D. Kao, B. A. Garcia, J. Shabanowitz, D. F. Hunt, J. Qin, C. Phelan, and M. A. Lazar. 2006. A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity. Genes Dev. 20:2566–2579.
   PubMed Web of Science ®Google Scholar
• Luo, J., A. Y. Nikolaev, S. Imai, D. Chen, F. Su, A. Shiloh, L. Guarente, and W. Gu. 2001. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107:137–148.
   PubMed Web of Science ®Google Scholar
• Marks, P., R. A. Rifkind, V. M. Richon, R. Breslow, T. Miller, and W. K. Kelly. 2001. Histone deacetylases and cancer: causes and therapies. Nat. Rev. Cancer 1:194–202.
   PubMed Web of Science ®Google Scholar
• Marks, P. A. 2007. Discovery and development of SAHA as an anticancer agent. Oncogene 26:1351–1356.
   PubMed Web of Science ®Google Scholar
• Ng, H. H., and A. Bird. 2000. Histone deacetylases: silencers for hire. Trends Biochem. Sci. 25:121–126.
   PubMed Web of Science ®Google Scholar
• Ono, R., T. Taki, T. Taketani, H. Kawaguchi, M. Taniwaki, T. Okamura, K. Kawa, R. Hanada, M. Kobayashi, and Y. Hayashi. 2002. SEPTIN6, a human homologue to mouse Septin6, is fused to MLL in infant acute myeloid leukemia with complex chromosomal abnormalities involving 11q23 and Xq24. Cancer Res. 62:333–337.
   PubMed Web of Science ®Google Scholar
• Patra, S. K., A. Patra, and R. Dahiya. 2001. Histone deacetylase and DNA methyltransferase in human prostate cancer. Biochem. Biophys. Res. Commun. 287:705–713.
   PubMed Web of Science ®Google Scholar
• Paulson, J. R., and S. S. Taylor. 1982. Phosphorylation of histones 1 and 3 and nonhistone high mobility group 14 by an endogenous kinase in HeLa metaphase chromosomes. J. Biol. Chem. 257:6064–6072.
   PubMed Web of Science ®Google Scholar
• Peart, M. J., G. K. Smyth, R. K. van Laar, D. D. Bowtell, V. M. Richon, P. A. Marks, A. J. Holloway, and R. W. Johnstone. 2005. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. Proc. Natl. Acad. Sci. USA 102:3697–3702.
   PubMed Web of Science ®Google Scholar
• Richon, V. M., T. W. Sandhoff, R. A. Rifkind, and P. A. Marks. 2000. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc. Natl. Acad. Sci. USA 97:10014–10019.
   PubMed Web of Science ®Google Scholar
• Richon, V. M., Y. Webb, R. Merger, T. Sheppard, B. Jursic, L. Ngo, F. Civoli, R. Breslow, R. A. Rifkind, and P. A. Marks. 1996. Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. Proc. Natl. Acad. Sci. USA 93:5705–5708.
   PubMed Web of Science ®Google Scholar
• Sasaki, S., L. A. Lesoon-Wood, A. Dey, T. Kuwata, B. D. Weintraub, G. Humphrey, W. M. Yang, E. Seto, P. M. Yen, B. H. Howard, and K. Ozato. 1999. Ligand-induced recruitment of a histone deacetylase in the negative-feedback regulation of the thyrotropin beta gene. EMBO J. 18:5389–5398.
   PubMedGoogle Scholar
• Taddei, A., C. Maison, D. Roche, and G. Almouzni. 2001. Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases. Nat. Cell Biol. 3:114–120.
   PubMed Web of Science ®Google Scholar
• Vance, K. W., S. Carreira, G. Brosch, and C. R. Goding. 2005. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. Cancer Res. 65:2260–2268.
   PubMed Web of Science ®Google Scholar
• Vaziri, H., S. K. Dessain, E. Ng Eaton, S. I. Imai, R. A. Frye, T. K. Pandita, L. Guarente, and R. A. Weinberg. 2001. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107:149–159.
   PubMed Web of Science ®Google Scholar
• Weiss, R. H. 2003. p21Waf1/Cip1 as a therapeutic target in breast and other cancers. Cancer Cell 4:425–429.
   PubMedGoogle Scholar
• Wilson, A. J., D. S. Byun, N. Popova, L. B. Murray, K. L'Italien, Y. Sowa, D. Arango, A. Velcich, L. H. Augenlicht, and J. M. Mariadason. 2006. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J. Biol. Chem. 281:13548–13558.
   PubMed Web of Science ®Google Scholar
• Xu, W. S., G. Perez, L. Ngo, C. Y. Gui, and P. A. Marks. 2005. Induction of polyploidy by histone deacetylase inhibitor: a pathway for antitumor effects. Cancer Res. 65:7832–7839.
   PubMedGoogle Scholar
• Yang, X. J. 2005. Multisite protein modification and intramolecular signaling. Oncogene 24:1653–1662.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., N. Li, C. Caron, G. Matthias, D. Hess, S. Khochbin, and P. Matthias. 2003. HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. EMBO J. 22:1168–1179.
   PubMed Web of Science ®Google Scholar
• Zhu, P., E. Martin, J. Mengwasser, P. Schlag, K. P. Janssen, and M. Gottlicher. 2004. Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell 5:455–463.
   PubMed Web of Science ®Google Scholar